Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Exeter moved sites - hence the delay
The Exeter nightingale was only just completed though, unless they were that far behind.
Believe they are all on standby until further notice. Which suggests they are wary of a 2nd wave this winter.
I'd like to see some commercial hires at GDR. 40 people, 2 commercial. It's a tough ask I feel to enter multiple markets and manage disti channels and direct sales oops in the millions with 2 heads.
@Dreammachine - I reckon they are realising that their sales team does not have Europe covered (all saturated thanks, with stocks or forward purchases of other PCR tests, even if not as good as GDR), that US competition let alone approvals is a huge challenge, and that India same story e.g. that Mr Divoc cannot pull strings and so on. What worries me is there may be a part of the BOD agenda that's starting to have to work out how to inform the market that the Covid-19 sales are not in fact coming, or that the indicative £1m (which is poorer than any of us would have liked) turns into a real £100K. I so, so hope I am completely wrong on all that. Good luck everyone.
No - Nightingale Hosp were surely part of the headless chicken process in which our Gov't engaged, for the 1st wave, not a part of the plan for any 2nd. Same headless chicken as buying gzillions of tests that don't really work, quarantining airport arrivals after the horse is in the stable, and figuring out that a sneeze distributes droplets over a wider area esp in spaces with air circulation systems. This is the rush-rush that created the hype for the Covid stocks before there was really anything to sell, NCYT excepted.
I agree LP.
I believe the Nightingale Hospitals were built with a 2nd Wave in mind ?
Sent an email to walbrook this afternoon asking for clarification on the reasons for our late submission into india and America. hoping for a logical response and not one hidden in corporate bullsh it. But will share if worthwhile. Does anyone email DB directly? On a few other holdings there seems to be direct contact.
I'll probably top up later In the week, But will have a strick exit point for that tranche.
In terms of outlook, all I'm hearing is that the virus is worsening worldwide. I cant see anything but a 2nd wave this winter. Is there anyone here who thinks otherwise? If so, would be interested to hear your reasoning.
I think 100p plus is doable again, just need the CEO to update shareholders. If he'd done that in June the share price would have held up better and people wouldn't be so frustrated. Bizarre that he disregards the share price so much.
props, my initial buy was at 27p and saw it rocket to 300. Then when it fell to £1.30 just before July , thought I'd be clever and buy more and now my average is 70p. In my defense?, I thought DB would deliver on his promise... :-//
Down over £7k now, hence the increased stress levels., Could really do with some sort of decent news, just not prepared to write that off..
Those little beads definitely look sellable!
My ave is 68 from a while a go, stupidly didn't take any out on the big rise and just watching it hit my ave again..
The big question is do I breakeven and go elsewhere or wait and let this play out??
I have similar ave at SNG and have averaged down over there...
@LB28, I know share price for a traditional firm is the present value of future profits. However this does not apply to most AIM listed shares as the firms are yet to generate any profits. They are simply priced on expectations some which can be substantiated based on fundamentals whereas others are on hype.
I bought GDR on expectation that they will have massive sales and at some point the income will exceed costs generating profits. With no reported sales, patience is running low with most PI. It may explode in future, but if the price keeps dropping any more most will desert it even with loss.
This is the GDR board Faz
@bladderman - no rainbow chasing at all, just do some research on Hemo and you’ll soon realise they’ve got big projects in the pipeline and the sp even at the moment is way undervalued. This will be £1+ in next 6-12 months imo
I have been watching HEMO for a while and everytime I think of taking a punt around 5.50p I refrain as most boards outside of HEMO say they have no product. Frustratingly GDR has a product but no sales. Sometimes, it feels the whole AIM is simply gambling rather than true investing as most time share prices defies the fundamentals.
I really hope David reads this board still so he can see the grief shareholders in his ****ty company have to put up with....
Total incompetence by DB. Oh lets just sit back and watch the sp slide from 300 to 70p. Cant even remember the last blue day. The pandemic is reaching records numbers per day but our 'unique' product isn't selling. Questions need to be asked why our approvals are taking longer than anyone else. DB really does need to pull his finger out his backside and show some results. All very well having a fancy product......if you can't sell it whats the point!!
whereas this is only going one way....down lol
Rainbow chasing on a share that has done 50% could mean one gets spiked. Could go either way
Sack this off and jump into Hemo! Big news landed just now
No, not DB. There was an article a day or so ago that stated USA needs low ball park 900,000 tests a day to the what seemed an impossible amount of a high ballpark of 10 mill tests a day to get on top of this. We are looking to sell, seen someones calc the other day was it 1530ish x full sets of 96 a week from the full world. to get around 1.5mill a week. With all the negativity does anyone not believe we can manage that. Then we have the other tests, got to be a buy from this price to what is in the pipe line. I am not trying to ramp. The new CE mark with the software opens up our Covid product to more open devices used in labs manufactured by the likes of Roche. We will have a covid test that is top notch that can prob be used on most machines in the current labs. Therefore it can displace the first to market if we are competitive on price as we already have a high spec. Go read the last 2 RNS and put it all together. Yip waiting on news, up at 6.59 each morning same as you looking for an RNS. Last comment for today. Good luck to you all, we win when it rises, bring it on David Budd.
I’ve averaged down a few times but every time I do it drops again and I end up the same percentage down as I started, you have to laugh .
50% down here but still remain confident. Lots of potential news to come that will help push this back up, have definately reigned in my expectations though.
Wish I could average down more but have already averaged down too much over the last few weeks.
Was the RNS really that bad. This is pioneering technology there are always snags. The cash is good and the DoD contract is looking good. The rest is on track technically albeit slower than we’d hope.
Much of the fall has been exacerbated by the illiquidity with there being so few shares for a small mcap. Ironically one of the attractions for investing here, hence it goes down ‘disproportionately’ but it should also rise ‘disproportionately’.
Many folk here will need a 100% rise to get back to evens. That’s only £38m which with the right news is achievable.
The problem that we will have from here is traders buying now and selling into news. It’s all part and parcel but they should be out fairly quickly.
The poc rapid test due end of year will imo change everything. That’s primarily why I invested. I truly believe that that will be massively transformational. It will be a superior bit of kit that many establishments will want on hand.
Trek
@Dave, wholeheartedly agree, this will recover quickly once traders buy in larger volumes...
Down on SNG and this one, depressing to watch, they both await the same thing, News, please let it be positive, not only for us but in the fight against Covid...